Is Everything a Challenge for Multiple Sclerosis patients? Nonverbal Semantic Memory Performance in Iranian Relapsing-Remitting Multiple Sclerosis Patients

被引:0
|
作者
Yazdani, Sara [1 ]
Sharifi, Shahla [1 ]
Foroughipour, Mohsen [2 ]
Gol, Atiyeh Kamyabi [1 ]
机构
[1] Ferdowsi Univ Mashhand, Linguist Dept, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Neurol Dept, Gaem Hosp, Mashhad, Razavi Khorasan, Iran
来源
BANGLADESH JOURNAL OF MEDICAL SCIENCE | 2021年 / 20卷 / 02期
关键词
nonverbal information; semantic memory; Multiple sclerosis; Iran; COGNITIVE IMPAIRMENT; INFORMATION; NEURODEGENERATION; DEMYELINATION; DEMENTIA; DEFICITS;
D O I
10.3329/bjms.v20i2.51554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The objective of the current study was to evaluate the nonverbal semantic memory performance of MS patients and compare it with their healthy counterparts. Materials and methods: In this study, 70 patients with definite relapsing-remitting multiple selerosis(15 men and 55 women) and 70 healthy individuals of comparable demographics (age, gender, and education) from patients' relatives and family members were selected based on convenient sampling. The patients recruited for this study were divided into two groups based on their Montreal Cognitive Assessment (MoCA) scores. The first group of patients (MS1) with MoCA scores of 18-25, and the MoCA scores of the second group (MS2) ranged from 10 -17. All of the participants were right-handed, originally born in Mashhad, Iran, and native speakers of Persian. To assess the nonverbal semantic memory performance of the participants, the picture version of The Camel and Cactus Test (CCT) was selected and administered from the Cambridge Semantic Memory battery test. Results: The results revealed that there was no significant difference between the MS1 and the Healthy Controls group in living and man-made variables, while MS2 performed significantly different compared to other groups in these variables. The results also showed that all three groups of participants performed significantly different from each other in reaction time variable. Conclusion: The findings showed that cognitive impairment in multiple sclerosis patients did not affect their nonverbal semantic memory performance, however, it had an impact on their reaction time.
引用
收藏
页码:390 / 395
页数:6
相关论文
共 50 条
  • [21] Sexual dysfunction in female patients with relapsing-remitting multiple sclerosis
    Bartnik, Pawel
    Wielgos, Aleksandra
    Kacperczyk, Joanna
    Pisarz, Katarzyna
    Szymusik, Iwona
    Podlecka-Pietowska, Aleksandra
    Zakrzewska-Pniewska, Beata
    Wielgos, Miroslaw
    BRAIN AND BEHAVIOR, 2017, 7 (06):
  • [22] Abnormal multisensory integration in relapsing-remitting multiple sclerosis
    Giurgola, Serena
    Casati, Carlotta
    Stampatori, Chiara
    Perucca, Laura
    Mattioli, Flavia
    Vallar, Giuseppe
    Bolognini, Nadia
    EXPERIMENTAL BRAIN RESEARCH, 2022, 240 (03) : 953 - 968
  • [23] Cognitive Performance in Relapsing-Remitting Multiple Sclerosis: At Risk or Impaired?
    Altieri, Marta
    Fratino, Mariangela
    Maestrini, Ilaria
    Dionisi, Claudia
    Annecca, Rosanna
    Vicenzini, Edoardo
    Di Piero, Vittorio
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2021, 49 (06) : 539 - 543
  • [24] Executive functions in relapsing-remitting multiple sclerosis
    Elosua, M. Rosa
    Villadangos, Noelia
    APPLIED NEUROPSYCHOLOGY-ADULT, 2023,
  • [25] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Guo, Rui
    Zhang, Fubo
    Zhang, Chao
    Dong, Shuai
    Zhou, Hongyu
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [26] Depression in relapsing-remitting multiple sclerosis
    Mendes, MF
    Tilbery, CP
    Balsimelli, S
    Moreira, MA
    Barao-Cruz, AM
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (3A) : 591 - 595
  • [27] Cognitive Impairment In Relapsing-Remitting Multiple Sclerosis
    Topcular, Baris
    Ozcan, M. Emin
    Kurt, Elif
    Kuscu, Demet Yandim
    Icen, Nilufer Kale
    Sutlas, Pakize Nevin
    Kirbas, Dursun
    Bingol, Ayhan
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2012, 49 (03): : 178 - 182
  • [28] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [29] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [30] Social norms in patients with relapsing-remitting multiple sclerosis: Impairment of the moral/conventional distinction?
    Ehrle, Nathalie
    Hody, Anais
    Lecrique, Maud
    Gury, Pauline
    Bakchine, Serge
    SOCIAL NEUROSCIENCE, 2020, 15 (06) : 630 - 640